Understand the source comparison
Epithalon Dosing vs Administration: Protocol Comparison
Standard Human Protocol 10mg/day 10 days 4–6 months Khavinson melatonin studies (2003–2011) Most evidence-supported for circadian restoration and general anti-aging Extended Longevity Protocol 5–10mg/day 20 days 6 months Animal lifespan extension studies Used
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard Human Protocol
- 10mg/day
- 10 days
- 4–6 months
- Khavinson melatonin studies (2003–2011)
- Most evidence-supported for circadian restoration and general anti-aging
- Extended Longevity Protocol
- 5–10mg/day
- 20 days
- 6 months
- Animal lifespan extension studies
- Used when telomere lengthening is the primary goal. No evidence it outperforms 10-day cycles
- High-Frequency Variant
- 5mg/day
- 3–4 months (3 cycles/year)
- Anecdotal researcher reports
- Lacks published validation. Risks receptor tolerance
- Conservative Protocol
- 6–12 months
- Derived from anti-aging clinical prudence
- Minimises unknown long-term risks but may underutilise peptide's potential